Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCXT-2001 in Healthy Adult Participants
NCT07792928Phase 1Not yet recruiting
- Sponsor
- Peptidstar Therapeutics
- Start
- Oct 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HCXT-2001 in psoriasis (8 cohorts), sponsored by Peptidstar Therapeutics. Primary endpoint: Number of participants with Adverse Events. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
HCXT-2001
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07792928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07792928.